Stay updated with breaking news from லேடிடியா பெரியது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
POLITICO Get the POLITICO Global Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. THE BIG IDEA A health care worker inoculates a woman with a Covid vaccine at a district hospital in the outskirts of New Delhi on April 22, 2021. | Photo by Anindito Mukherjee/Getty Images WHAT HAPPENS NOW FOR IP WAIVER TALKS ....
January 29, 2021 Cooperative manufacturing isn’t unheard of in the pharmaceutical world, but it’s not common. The demands of the Covid-19 pandemic, however, have turned rival companies into manufacturing allies. On Jan. 27, the French drug company Sanofi announced that it would help BioNTech manufacture some 125 million doses of its mRNA-based Covid-19 vaccine for the European Union (EU). This collaboration is unique in the pharmaceutical industry: Sanofi and BioNTech are direct competitors in the vaccine world, the former still hoping to launch its own Covid-19 vaccine within the year. But they’re not alone. AstraZeneca, which has been criticized for its slow pace of vaccine production in the EU, partnered with JCR Pharmaceuticals in Japan and the Serum Institute of India to ramp up manufacturing. Moderna has partnered with the Swiss chemical company Lonza Group AG to manufacture vaccines and is seeking other partners, Bloomberg reports. ....